Pharmadrug Inc. (LMLLF)
LMLLF Stock Price Chart
Explore Pharmadrug Inc. interactive price chart. Choose custom timeframes to analyze LMLLF price movements and trends.
LMLLF Company Profile
Discover essential business fundamentals and corporate details for Pharmadrug Inc. (LMLLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
19 May 2017
Employees
—
Website
https://www.pharmadrug.caCEO
Robert J. Steen
Description
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.
LMLLF Financial Timeline
Browse a chronological timeline of Pharmadrug Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 May 2026
Upcoming earnings on 21 May 2026
Upcoming earnings on 7 Nov 2025
Earnings released on 7 Aug 2025
Earnings released on 30 Apr 2025
EPS came in at -$0.00 .
Earnings released on 29 Apr 2025
EPS came in at $0.00 .
Earnings released on 11 Oct 2024
EPS came in at -$0.00 .
Earnings released on 30 Sept 2024
EPS came in at -$0.00 .
Earnings released on 30 Mar 2024
EPS came in at -$0.00 .
Earnings released on 4 Jan 2024
EPS came in at -$0.00 .
Earnings released on 31 Dec 2023
EPS came in at -$0.16 .
Stock split effective on 24 Oct 2023
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$0.01 .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 .
Earnings released on 31 Dec 2022
EPS came in at -$0.01 , while revenue for the quarter reached -$2.53K .
Earnings released on 30 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $1.85K .
Earnings released on 30 Jun 2022
EPS came in at -$0.08 .
Earnings released on 31 Mar 2022
EPS came in at -$0.03 , while revenue for the quarter reached $82.13K .
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $79.95K .
Earnings released on 30 Sept 2021
EPS came in at -$0.02 , while revenue for the quarter reached $113.21K .
Earnings released on 30 Jun 2021
EPS came in at -$0.02 , while revenue for the quarter reached $91.05K .
Earnings released on 31 Mar 2021
EPS came in at -$0.03 , while revenue for the quarter reached $108.72K .
Earnings released on 31 Dec 2020
EPS came in at -$0.09 , while revenue for the quarter reached $137.40K .
Earnings released on 30 Sept 2020
EPS came in at -$0.03 , while revenue for the quarter reached $103.15K .
LMLLF Stock Performance
Access detailed LMLLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.